Antioxidant-mediated hepatoprotective effects of Citrus aurantifolia peels extract in doxorubicin-induced liver injury: Acute and sub-acute toxicity assessment in rats
Nigerian Journal of Pharmaceutical Research · 18.05.2026 · 21 (2) · 131-142
DOI: 10.4314/njpr.v21i2.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nigerian Journal of Pharmaceutical Research, online erschienen am 18.05.2026. Verfasst von E. O. Oyinloye und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The liver plays a crucial role in metabolism and detoxification but remains highly susceptible to oxidative stress induced by chemotherapeutic agents such as doxorubicin (DOX). DOX promotes the generation of reactive oxygen species (ROS), resulting in lipid peroxidation, inflammation, and hepatocellular degeneration. Medicinal plants have attracted growing interest for their potential to alleviate oxidative damage.
Objective
This study aimed to evaluate the antioxidant-mediated hepatoprotective effects of Citrus aurantifolia peels extract against doxorubicin-induced liver injury in rats, alongside assessing its acute and sub-acute toxicity profile.
Method
Acute and sub-acute toxicity studies were carried out in accordance with OECD guidelines. Hepatotoxicity was induced by intraperitoneal administration of DOX (15 mg/kg), followed by oral treatment with CAPE (100, 200, and 400 mg/kg) or alpha-lipoic acid (150 mg/kg) for seven days. Changes in body weight, hematological indices, and antioxidant markers (superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA) and Vitamins C) were assessed. Liver tissues were also examined histologically.
Results
CAPE was well tolerated up to 2000 mg/kg, indicating a broad safety margin. Repeated administration at 200–400 mg/kg caused no mortality or clinical signs of toxicity, though mild lethargy was observed at 800 mg/kg. CAPE significantly (p
Zitieren
APA
Oyinloye, E. O., Murtala, A. A., Oladoja, F. A., Aderinola, A. A., Tijani, R. O., & Soyinka, O. O. (2026). Antioxidant-mediated hepatoprotective effects of Citrus aurantifolia peels extract in doxorubicin-induced liver injury: Acute and sub-acute toxicity assessment in rats. Nigerian Journal of Pharmaceutical Research, 21(2), 131-142. https://doi.org/10.4314/njpr.v21i2.9
Vancouver
Oyinloye EO, Murtala AA, Oladoja FA, Aderinola AA, Tijani RO, Soyinka OO. Antioxidant-mediated hepatoprotective effects of Citrus aurantifolia peels extract in doxorubicin-induced liver injury: Acute and sub-acute toxicity assessment in rats. Nigerian Journal of Pharmaceutical Research. 2026;21(2):131-142. doi:10.4314/njpr.v21i2.9
BibTeX
@article{Oyinloye2026,
author = {Oyinloye, E. O. and Murtala, A. A. and Oladoja, F. A. and Aderinola, A. A. and Tijani, R. O. and Soyinka, O. O.},
title = {Antioxidant-mediated hepatoprotective effects of Citrus aurantifolia peels extract in doxorubicin-induced liver injury: Acute and sub-acute toxicity assessment in rats},
journal = {Nigerian Journal of Pharmaceutical Research},
year = {2026},
volume = {21},
number = {2},
pages = {131--142},
doi = {10.4314/njpr.v21i2.9}
}
EUVIMED